{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:22:58Z","timestamp":1789521778770,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018ZX09711001-003-010"],"award-info":[{"award-number":["2018ZX09711001-003-010"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2019-I2M-1-001"],"award-info":[{"award-number":["2019-I2M-1-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621064"],"award-info":[{"award-number":["81621064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.113083","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T06:55:14Z","timestamp":1652165714000},"page":"113083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6\/STAT3 signaling pathway"],"prefix":"10.1016","volume":"150","author":[{"given":"Hu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Li","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Gen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2022.113083_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.biopha.2022.113083_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017020927","article-title":"Hepatocellular carcinoma and possible chemical and biological causes: a review","volume":"36","author":"Erkekoglu","year":"2017","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.biopha.2022.113083_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J. Hepatol."},{"issue":"13","key":"10.1016\/j.biopha.2022.113083_bib6","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/1873-3468.12689","article-title":"Deletion of HNF1alpha in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice","volume":"591","author":"Ni","year":"2017","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biopha.2022.113083_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","article-title":"Interleukin-6 as a therapeutic target","volume":"21","author":"Rossi","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2022.113083_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/ars.2021.0076","article-title":"Signal transduction and molecular regulation in fatty liver disease","volume":"35","author":"Dong","year":"2021","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.biopha.2022.113083_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-kappaB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2022.113083_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s40265-019-01126-9","article-title":"Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities","volume":"79","author":"Manka","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2022.113083_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/157340609787049316","article-title":"Bicyclol: a novel drug for treating chronic viral hepatitis B and C","volume":"5","author":"Liu","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.biopha.2022.113083_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107308","article-title":"Therapeutic potential of bicyclol in liver diseases: lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine","volume":"91","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113083_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/10286021003789047","article-title":"Effects of bicyclol on immunological liver fibrosis in rats","volume":"12","author":"Gu","year":"2010","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"24","key":"10.1016\/j.biopha.2022.113083_bib15","first-page":"2096","article-title":"Protective effects of bicyclol on liver fibrosis induced by carbon tetrachloride","volume":"84","author":"Li","year":"2004","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"23","key":"10.1016\/j.biopha.2022.113083_bib16","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.3748\/wjg.v21.i23.7155","article-title":"Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats","volume":"21","author":"Zhen","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113083_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.apsb.2019.01.013","article-title":"Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication","volume":"9","author":"Huang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.biopha.2022.113083_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039700","article-title":"Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.biopha.2022.113083_bib19","article-title":"Combined use of bicyclol and berberine alleviates mouse nonalcoholic fatty liver disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113083_bib21","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113083_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2022.113083_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmed.2017.00193","article-title":"Histological grading of hepatocellular carcinoma-a systematic review of literature","volume":"4","author":"Martins-Filho","year":"2017","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.113083_bib24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for non-alcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2022.113083_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24084","article-title":"An improved experimental method for simultaneously isolating hepatocytes and hepatic stellate cells in mouse liver infected with Echinococcus multilocularis","volume":"35","author":"Bi","year":"2021","journal-title":"J. Clin. Lab Anal."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.biopha.2022.113083_bib27","first-page":"629","article-title":"Bifendate indirectly inhibits alanine transaminase release without direct interaction in vitro and in vivo","volume":"77","author":"Li","year":"2020","journal-title":"Acta Pol. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2022.113083_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102759","article-title":"Cellular and molecular mechanisms underlying liver fibrosis regression","volume":"10","author":"Caligiuri","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2022.113083_bib29","article-title":"Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"3","author":"Younossi","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.biopha.2022.113083_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105151","article-title":"Essential role of STAT-3 dependent NF-kappaB activation on IL-6-mediated downregulation of hepatic transporters","volume":"143","author":"Abualsunun","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2022.113083_bib31","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: From physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113083_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ddr.21451","article-title":"Protective role of fucoxanthin in diethylnitrosamine-induced hepatocarcinogenesis in experimental adult rats","volume":"80","author":"Jin","year":"2019","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.biopha.2022.113083_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00432-017-2364-z","article-title":"Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine","volume":"143","author":"Ding","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.biopha.2022.113083_bib35","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.3748\/wjg.v18.i30.3962","article-title":"Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues","volume":"18","author":"Jia","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"47","key":"10.1016\/j.biopha.2022.113083_bib36","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3748\/wjg.v24.i47.5297","article-title":"Hepatitis C: from inflammatory pathogenesis to anti-inflammatory\/hepatoprotective therapy","volume":"24","author":"Li","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113083_bib37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12885-016-2767-2","article-title":"Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K\/AKT and Ras\/Raf\/MEK\/ERK pathways","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2022.113083_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/10286020902942368","article-title":"Inhibitory effect of anti-hepatitis drug bicyclol on invasion of human hepatocellular carcinoma MHCC97-H cells with high metastasis potential and its relative mechanisms","volume":"11","author":"Sun","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2022.113083_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/584728","article-title":"A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model","volume":"2012","author":"Sun","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113083_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12876-019-1005-1","article-title":"Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience","volume":"19","author":"Chi","year":"2019","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113083_bib41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ptr.5541","article-title":"Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK\/Nrf2 pathway","volume":"30","author":"Qu","year":"2016","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113083_bib42","first-page":"46","article-title":"Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma","volume":"1835","author":"Subramaniam","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"31","key":"10.1016\/j.biopha.2022.113083_bib43","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3748\/wjg.v18.i31.4071","article-title":"Inflammation- and stress-related signaling pathways in hepatocarcinogenesis","volume":"18","author":"Nakagawa","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.113083_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/JHC.S272213","article-title":"NAFLD-associated HCC: progress and opportunities","volume":"8","author":"Geh","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"5","key":"10.1016\/j.biopha.2022.113083_bib45","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2022.113083_bib46","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1111\/j.1572-0241.2008.02161_17.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human non-alcoholic steatohepatitis","volume":"103","author":"Dogru","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.113083_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111874","article-title":"Bicyclol ameliorates non-alcoholic fatty liver disease in mice via inhibiting MAPKs and NF-kappaB signaling pathways","volume":"141","author":"Zhao","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113083_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2020.00463","article-title":"Bicyclol attenuates acute liver injury by activating autophagy, anti-oxidative and anti-inflammatory capabilities in mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113083_bib49","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fphar.2018.01438","article-title":"Bicyclol attenuates liver inflammation induced by infection of hepatitis c virus via repressing ROS-mediated activation of MAPK\/NF-kappaB signaling pathway","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113083_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2013.07.008","article-title":"STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib","volume":"46","author":"Deng","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2022.113083_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: a key regulator in liver fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113083_bib52","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2022.113083_bib53","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/hep.21427","article-title":"Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells","volume":"44","author":"Nieto","year":"2006","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2022.113083_bib54","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2014.07.025","article-title":"Stat3 signaling activation crosslinking of TGF-beta1 in hepatic stellate cell exacerbates liver injury and fibrosis","volume":"1842","author":"Xu","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.biopha.2022.113083_bib55","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3748\/wjg.v19.i15.2307","article-title":"Role of interleukin-6 in Barrett\u2019s esophagus pathogenesis","volume":"19","author":"Dvorak","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer--new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2022.113083_bib57","first-page":"1337","article-title":"S-allyl-cysteine attenuates carbon tetrachloride-induced liver fibrosis in rats by targeting STAT3\/SMAD3 pathway","volume":"10","author":"Gong","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113083_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0254-6272(16)30030-9","article-title":"Panax notoginseng saponins ameliorates experimental hepatic fibrosis and hepatic stellate cell proliferation by inhibiting the Jak2\/ Stat3 pathways","volume":"36","author":"Hui","year":"2016","journal-title":"J. Tradit. Chin. Med."},{"issue":"18","key":"10.1016\/j.biopha.2022.113083_bib59","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-16-2253","article-title":"Multifunctional effects of a small-molecule STAT3 inhibitor on NASH and hepatocellular carcinoma in mice","volume":"23","author":"Jung","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113083_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:39:29Z","timestamp":1780486769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222004723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"alternative-id":["S0753332222004723"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113083","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6\/STAT3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113083"}}